Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022

SELL
$138.87 - $214.31 $1.32 Million - $2.03 Million
-9,490 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$170.18 - $198.21 $107 Million - $125 Million
-628,666 Reduced 98.51%
9,490 $1.8 Million
Q2 2021

Jul 28, 2021

BUY
$158.62 - $194.3 $1.61 Million - $1.97 Million
10,150 Added 1.62%
638,156 $113 Million
Q1 2021

May 24, 2021

BUY
$132.02 - $168.26 $82.9 Million - $106 Million
628,006 New
628,006 $103 Million
Q1 2021

May 03, 2021

SELL
$132.02 - $168.26 $109 Million - $138 Million
-823,020 Closed
0 $0
Q4 2020

Jan 21, 2021

SELL
$109.38 - $149.19 $414,659 - $565,579
-3,791 Reduced 0.46%
823,020 $115 Million
Q3 2020

Nov 02, 2020

SELL
$92.95 - $130.61 $23.3 Million - $32.7 Million
-250,476 Reduced 23.25%
826,811 $92.4 Million
Q2 2020

Aug 07, 2020

SELL
$68.08 - $95.68 $1.16 Million - $1.63 Million
-17,005 Reduced 1.55%
1,077,287 $100 Million
Q1 2020

May 04, 2020

SELL
$61.71 - $101.95 $11.3 Million - $18.7 Million
-183,774 Reduced 14.38%
1,094,292 $80.3 Million
Q4 2019

Feb 06, 2020

BUY
$70.08 - $84.64 $1.45 Million - $1.75 Million
20,663 Added 1.64%
1,278,066 $107 Million
Q3 2019

Nov 12, 2019

SELL
$62.38 - $85.89 $17.4 Million - $24 Million
-279,193 Reduced 18.17%
1,257,403 $106 Million
Q2 2019

Aug 01, 2019

BUY
$53.64 - $65.42 $2.91 Million - $3.55 Million
54,267 Added 3.66%
1,536,596 $0
Q1 2019

May 01, 2019

SELL
$49.38 - $70.58 $5.48 Million - $7.84 Million
-111,058 Reduced 6.97%
1,482,329 $0
Q4 2018

Jan 30, 2019

BUY
$46.97 - $63.98 $74.1 Million - $101 Million
1,577,640 Added 10018.67%
1,593,387 $84.3 Million
Q3 2018

Nov 05, 2018

SELL
$43.25 - $63.74 $335,663 - $494,686
-7,761 Reduced 33.01%
15,747 $0
Q2 2018

Jul 18, 2018

BUY
$34.03 - $45.46 $26,713 - $35,686
785 Added 3.45%
23,508 $0
Q4 2017

Feb 06, 2018

BUY
$32.46 - $38.31 $737,588 - $870,518
22,723
22,723 $0

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.